Addiction Medicine Part 2: Alcohol
14.95
About the Course
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17 (National Institute on Alcohol Abuse and Alcoholism, 2021). There are over 95,000 deaths every year that are directly attributed to alcohol use, and the economic cost of alcohol use is astounding: excessive alcohol use in the United States is said to cost nearly $250 billion annually (Centers for Disease Control and Prevention, 2019). In the United States, alcohol use disorder has a lifetime prevalence of approximately 29%. Despite the high prevalence and common complications, alcohol use disorder is undertreated. Less than 10% of patients with a diagnosis of alcohol use disorder in the past 12 months receive any treatment, and only around 6% of patients with alcohol use disorder receive evidence-based care (Reus et al, 2018). There is a clear need for improvement in the treatment of this common condition; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder.
Learning Outcomes
Alcohol use disorder is a serious national health problem in the United States. It is estimated that more than 14 million American adults had an alcohol use disorder in 2019, as well as 414,000 adolescents aged 12 to 17 (National Institute on Alcohol Abuse and Alcoholism, 2021). There are over 95,000 deaths every year that are directly attributed to alcohol use, and the economic cost of alcohol use is astounding: excessive alcohol use in the United States is said to cost nearly $250 billion annually (Centers for Disease Control and Prevention, 2019). In the United States, alcohol use disorder has a lifetime prevalence of approximately 29%. Despite the high prevalence and common complications, alcohol use disorder is undertreated. Less than 10% of patients with a diagnosis of alcohol use disorder in the past 12 months receive any treatment, and only around 6% of patients with alcohol use disorder receive evidence-based care (Reus et al, 2018). There is a clear need for improvement in the treatment of this common condition; this course serves to review the recognition, diagnosis, and treatment of alcohol use disorder.
Learning Outcomes
- Summarize the complications associated with alcohol use, including inebriation, withdrawal, and long term complications.
- Describe current best practices for the treatment of alcohol withdrawal.
- Explain the screening, diagnosis and treatment of alcohol use disorder, including pharmacological and non-pharmacological treatment options.
About the Author
Katie Blair, PharmD, RPh, is a pharmacist and freelance writer specializing in pharmacy education. She works as a consultant pharmacist in Vancouver, Washington, serving long-term care facilities in the area since 2016. Katie also has over six years of experience working as a staff pharmacist at a community pharmacy in Seattle, Washington. She graduated from Northeastern University in Boston in 2009 with a Doctor of Pharmacy degree. Katie has done freelance work writing and revising continuing education programs for pharmacists, pharmacy technicians, and nurses, as well as writing practice questions for various pharmacy technician exams.
How to Receive Credit
Katie Blair, PharmD, RPh, is a pharmacist and freelance writer specializing in pharmacy education. She works as a consultant pharmacist in Vancouver, Washington, serving long-term care facilities in the area since 2016. Katie also has over six years of experience working as a staff pharmacist at a community pharmacy in Seattle, Washington. She graduated from Northeastern University in Boston in 2009 with a Doctor of Pharmacy degree. Katie has done freelance work writing and revising continuing education programs for pharmacists, pharmacy technicians, and nurses, as well as writing practice questions for various pharmacy technician exams.
How to Receive Credit
- Read the entire course online or in print.
- Answer the final examination questions at the end of the course. A passing grade of 75% is required. Test questions link content to learning objectives as a method to enhance individualized learning and material retention.
- Provide required personal information and payment information.
- Complete the mandatory course evaluation.
- Print your Certificate of Completion.
Resolution of Conflict of Interest
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Colibri Healthcare, LLC implemented mechanisms prior to the planning and implementation of the continuing education activity, to identify and resolve conflicts of interest for all individuals in a position to control content of the course activity.
Sponsorship/Commercial Support and Non-Endorsement
It is the policy of Colibri not to accept commercial support. Furthermore, commercial interests are prohibited from distributing or providing access to this activity to learners.
Disclaimer
The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition.
©2022: All Rights Reserved. Materials may not be reproduced without the expressed written permission or consent of Colibri Healthcare, LLC. The materials presented in this course are meant to provide the consumer with general information on the topics covered. The information provided was prepared by professionals with practical knowledge of the areas covered. It is not meant to provide medical, legal, or professional advice. Colibri Healthcare, LLC recommends that you consult a medical, legal, or professional services expert licensed in your state. Colibri Healthcare, LLC has made all reasonable efforts to ensure that all content provided in this course is accurate and up to date at the time of printing but does not represent or warrant that it will apply to your situation nor circumstances and assumes no liability from reliance on these materials. Quotes are collected from customer feedback surveys. The models are intended to be representative and not actual customers.
Accreditations and Approvals
Colibri Healthcare, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. (Provider #0607). Your hours will be reported to CPE Monitor within 10 business days after course completion. Colibri Healthcare, LLC is also approved through the Florida Board of Pharmacy (Provider #50-4007).
Target Audience
? Pharmacists